Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer

Samir S. Taneja

doi:10.1007/s11934-009-0002-2

Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	4-5
Number of pages	2
Journal	Current Urology Reports
Volume	10
Issue number	1
DOIs	https://doi.org/10.1007/s11934-009-0002-2
State	Published - Jan 2009

ASJC Scopus subject areas

Urology

Access to Document

10.1007/s11934-009-0002-2

Cite this

@article{839ebc2518824bea947ff09311377796,

title = "Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer",

author = "Taneja, {Samir S.}",

year = "2009",

month = jan,

doi = "10.1007/s11934-009-0002-2",

language = "English (US)",

volume = "10",

pages = "4--5",

journal = "Current Urology Reports",

issn = "1527-2737",

publisher = "Current Science, Inc.",

number = "1",

}

TY - JOUR

T1 - Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer

AU - Taneja, Samir S.

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=58149473118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149473118&partnerID=8YFLogxK

U2 - 10.1007/s11934-009-0002-2

DO - 10.1007/s11934-009-0002-2

M3 - Comment/debate

C2 - 19116088

AN - SCOPUS:58149473118

SN - 1527-2737

VL - 10

SP - 4

EP - 5

JO - Current Urology Reports

JF - Current Urology Reports

IS - 1

ER -

Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this